Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Greenwich LifeSciences

Market Cap: US$149.2m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania.

Mountain Valley MD Holdings

Market Cap: CA$5.3m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Algernon Pharmaceuticals

Market Cap: CA$2.4m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

MAIA Biotechnology

Market Cap: US$52.8m

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Arecor Therapeutics

Market Cap: UK£32.7m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Xbrane Biopharma

Market Cap: SEK 626.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

IO Biotech

Market Cap: US$104.1m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

C21 Investments

Market Cap: CA$61.2m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

Roquefort Therapeutics

Market Cap: UK£3.5m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Vitrolife

Market Cap: SEK 17.4b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

EXACT Therapeutics

Market Cap: NOK 126.5m

A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).

Green Thumb Industries

Market Cap: CA$2.6b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

China Pharma Holdings

Market Cap: US$6.5m

Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.

Revive Therapeutics

Market Cap: CA$6.5m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Jeil PharmaceuticalLtd

Market Cap: ₩208.2b

Develops and supplies pharmaceutical products primarily in South Korea.

bioXXmed

Market Cap: €312.6k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

AnGes

Market Cap: JP¥29.7b

Engages in the research and development of gene-based medical products.

GNI Group

Market Cap: JP¥135.4b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Astellas Pharma

Market Cap: JP¥3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Dong-A Socio Holdings

Market Cap: ₩745.9b

Engages in the pharmaceutical business in South Korea.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$2.0b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Cynata Therapeutics

Market Cap: AU$48.7m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

ABL Bio

Market Cap: ₩5.1t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥76.5b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Jiangsu Gdk Biological Technology

Market Cap: CN¥1.9b

Engages in the scientific research, production of human vaccines.

MGI Tech

Market Cap: CN¥28.0b

Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

Lukas Biomedical

Market Cap: NT$1.1b

Engages in the wholesale and retail of cosmetics in Taiwan.

Anxo Pharmaceutical

Market Cap: NT$1.3b

A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

HansBiomed

Market Cap: ₩234.9b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.5b

Shanghai Rightongene Biotechnology Co., Ltd.

Jiangsu Yahong Meditech

Market Cap: CN¥6.1b

A pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally.

Dezhan Healthcare

Market Cap: CN¥8.5b

Engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.

Frontage Holdings

Market Cap: HK$2.5b

A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.

Radiopharm Theranostics

Market Cap: AU$68.6m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Fuan Pharmaceutical (Group)

Market Cap: CN¥5.1b

Research and develops, produces, and sells chemical drugs in the People's Republic of China.

Taysha Gene Therapies

Market Cap: US$859.3m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.